WEBER CAPITAL MANAGEMENT LLC /ADV
Position in HBIO — Harvard Bioscience Inc
CIK 1099905
SAN FRANCISCO, CA
Position in HBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,911,795
+$353,215 QoQ
Shares Held
310,861
-2.9% QoQ
Ownership
6.83%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#1
of 37 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in HBIO Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026WEBER CAPITAL MANAGEMENT LLC /ADV holds $19,561,187 across 2 Medical Instruments & Supplies names. HBIO ranks #2 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANGO |
Angiodynamics Inc
|
1,356,602 | $17,649,392 | |
| 2 | HBIO |
Harvard Bioscience Inc
This page
|
310,861 | $1,911,795 |
All Filings in HBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,911,795 | 310,861 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,558,580 | 320,037 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,144,254 | 3,200,380 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||